2.6
2023

Successful dupilumab dose spacing in controlled severe atopic dermatitis and predictive factors

Show more: Authors information and Publication history
Authors Information

1Department of Immunoallergology, Unidade Local de Saúde da Arrábida E.P.E., Arrábida , Portugal
2Institute of Allergology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
3Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany

History

Published: 24 April 2025
Accepted: 11 February 2024
Received: 25 September 2024

KEY WORDS
Atopic dermatitis; dupilumab; dose reduction.

Table of Content: Online First

European Annals of Allergy and Clinical Immunology ISSN 1764-1489 | © 2024